Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2005 1
2006 1
2007 4
2008 2
2010 1
2011 2
2012 1
2013 3
2014 1
2015 2
2016 2
2017 8
2018 6
2019 3
2020 4
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.
Rayego-Mateos S, Morgado-Pascual JL, Opazo-Ríos L, Guerrero-Hue M, García-Caballero C, Vázquez-Carballo C, Mas S, Sanz AB, Herencia C, Mezzano S, Gómez-Guerrero C, Moreno JA, Egido J. Rayego-Mateos S, et al. Among authors: mas s. Int J Mol Sci. 2020 May 27;21(11):3798. doi: 10.3390/ijms21113798. Int J Mol Sci. 2020. PMID: 32471207 Free PMC article. Review.
Proteomics in atherosclerosis.
Martinez-Pinna R, Martin-Ventura JL, Mas S, Blanco-Colio LM, Tuñon J, Egido J. Martinez-Pinna R, et al. Among authors: mas s. Curr Atheroscler Rep. 2008 Jun;10(3):209-15. doi: 10.1007/s11883-008-0033-z. Curr Atheroscler Rep. 2008. PMID: 18489848 Review.
Atrasentan for the treatment of diabetic nephropathy.
Egido J, Rojas-Rivera J, Mas S, Ruiz-Ortega M, Sanz AB, Gonzalez Parra E, Gomez-Guerrero C. Egido J, et al. Among authors: mas s. Expert Opin Investig Drugs. 2017 Jun;26(6):741-750. doi: 10.1080/13543784.2017.1325872. Expert Opin Investig Drugs. 2017. PMID: 28468519 Review.
Protective Role of Nrf2 in Renal Disease.
Guerrero-Hue M, Rayego-Mateos S, Vázquez-Carballo C, Palomino-Antolín A, García-Caballero C, Opazo-Rios L, Morgado-Pascual JL, Herencia C, Mas S, Ortiz A, Rubio-Navarro A, Egea J, Villalba JM, Egido J, Moreno JA. Guerrero-Hue M, et al. Among authors: mas s. Antioxidants (Basel). 2020 Dec 31;10(1):39. doi: 10.3390/antiox10010039. Antioxidants (Basel). 2020. PMID: 33396350 Free PMC article. Review.
Vascular proteomics.
Vivanco F, Mas S, Darde VM, De la Cuesta F, Alvarez-Llamas G, Barderas MG. Vivanco F, et al. Among authors: mas s. Proteomics Clin Appl. 2007 Sep;1(9):1102-22. doi: 10.1002/prca.200700190. Proteomics Clin Appl. 2007. PMID: 21136761
Animal models of cardiovascular diseases.
Zaragoza C, Gomez-Guerrero C, Martin-Ventura JL, Blanco-Colio L, Lavin B, Mallavia B, Tarin C, Mas S, Ortiz A, Egido J. Zaragoza C, et al. Among authors: mas s. J Biomed Biotechnol. 2011;2011:497841. doi: 10.1155/2011/497841. Epub 2011 Feb 16. J Biomed Biotechnol. 2011. PMID: 21403831 Free PMC article. Review.
Targeting inflammation in diabetic nephropathy: a tale of hope.
Moreno JA, Gomez-Guerrero C, Mas S, Sanz AB, Lorenzo O, Ruiz-Ortega M, Opazo L, Mezzano S, Egido J. Moreno JA, et al. Among authors: mas s. Expert Opin Investig Drugs. 2018 Nov;27(11):917-930. doi: 10.1080/13543784.2018.1538352. Epub 2018 Oct 23. Expert Opin Investig Drugs. 2018. PMID: 30334635 Review.
43 results